Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 26 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase I/II Chemotherapy with N-MF in Patients with Metastatic Colorectal Adenocarcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				no age specified				NCI				MSKCC-83124A NCI-T83-1418C, T83-1418


2.		Phase I/II Chemotherapy with N-Methylformamide in Children with Drug-Resistant Malignant Solid Tumors and Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				under 18				NCI				SJCRH-NMF-I/II NCI-T83-1154D, T83-1154

Last Modified: 5/1/1988


3.		Phase I/II Study of Chemotherapy with N-Methylformamide in Patients with Chronic Myelogenous Leukemia (Summary Last Modified 05/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				18 and over				NCI				ICC-86H3 NCI-T85-0216D, T85-0216


4.		Phase II Chemotherapy with N-Methylformamide for Nonresectable Squamous Cell Carcinoma of the Head and Neck

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				UMCT-1583 NCI-T83-1262C, T83-1262


5.		Phase II Chemotherapy with N-MF for Advanced or Recurrent Adenocarcinoma of the Colon or Rectum

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				15 and over				NCI				UMCC-8313 NCI-T83-1076W, T83-1076


6.		Phase II Chemotherapy with N-Methylformamide for Stage III/IV Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				over 15				NCI				UMCC-8308 NCI-T83-1081W, T83-1081

Last Modified: 12/6/2007


7.		Phase II Pilot Chemotherapy with N-MF for Advanced Inoperable Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				MSKCC-8376A NCI-T83-1151C, T83-1151


8.		Phase II Master Protocol for Single-Agent Chemotherapy for Refractory Small Cell Bronchogenic Carcinoma --- Spirogermanium vs N-Methylformamide

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				EST-4583


9.		Phase II Master Protocol for Single-Agent Chemotherapy for Advanced non-Small Cell Lung Cancer --- 4-Demethoxydaunorubicin

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				EST-3583


10.		Phase II Chemotherapy with N-MF for Advanced Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				UMCT-2683 NCI-T83-1308C, T83-1308

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute